OUD

Integrating Opioid Use Disorder Treatment Into Primary Care Settings

Scientific article

11 August 2023

Abstract Importance Medication for opioid use disorder (MOUD) (eg, buprenorphine and naltrexone) can be offered in primary care, but barriers to implementation exist. Objective To evaluate an implementation intervention over 2 years to...

Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021

Scientific article

7 August 2023

Discussion Despite guidelines recommending MOUD, approximately 1 in 5 adults with past-year OUD received any MOUD. Furthermore, some groups were substantially less likely to receive MOUD, in particular Black adults, women, those unemployed...

FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder

News

For Immediate Release: May 23, 2023 Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...

Opioid Use Disorder in Pregnant and Postpartum People

31 May 2023

Washington, DC

United States

May 31, 2023, 03:00 PM (Washington, DC time)

Opioid Use Disorder in the Nursing Profession

Video and audio recordings

Presented by Kristin Waite-Labott, RN, BSN, CARN; April Lynn Lenzmeier, RN, DNP; Rachel Shuster, BSN, RN, CARN, CAAP. The American Nurses Association estimates that six to eight percent of nurses use alcohol or drugs to an extent that is...

The Intersection of DEA, Opioids, and MAT

27 April 2022

Online

- Global -

Wednesday, April 27, 2022 @ 3:00-4:00pm ET (2CT/1MT/12PT)

Description

As a result of the opioid crisis, more and more primary care providers are being asked to treat those suffering from opioid use disorder (OUD) through the use of medication assisted treatment (MAT).

High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder

Scientific article

15 July 2021

Abstract Importance: Emergency departments (EDs) sporadically use a high-dose buprenorphine induction strategy for the treatment of opioid use disorder (OUD) in response to the increasing potency of the illicit opioid drug supply and...

Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial

Scientific article

20 April 2021

Abstract Telemedicine (TM) enabled by digital health technologies to provide medical services has been considered a key solution to increasing health care access in rural communities. With the immediate need for remote care due to the COVID...

Plausibility of patient-centred care in high-intensity methadone treatment: Reflections of providers and patients

Scientific article

29 June 2021

Abstract Background: Patients with opioid use disorder (OUD) often have complex health care needs. Methadone is one of the medications for opioid use disorder (MOUD) used in the management of OUDs. Highly restrictive methadone treatment...

Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities

Scientific article

25 June 2021

Abstract Background: Opioid use disorder (OUD) disproportionately impacts rural and American Indian communities and has quadrupled among pregnant individuals nationwide in the past two decades. Yet, limited data are available about access...